Skip to content
Stop using now Drug recall · FDA · Published April 16, 2018

Euphoric Premium Male Performance Enhancer capsules: Unapproved drug ingredients

Epic Products recalls Euphoric Premium Male Performance Enhancer capsules due to undeclared FDA-approved drugs. All packaging with specific UPCs are affected. Stop using immediately to avoid unapproved drug risks.

🇺🇸 FDA recall #D-0288-2019DrugEpic Products ›
Take action

Contact the company

Recalling firmEpic Products, LLC11730 W 135th St, #224 · Overland Park, KS 66221-9395
✎ GovInfoNow plain-language explainer

What happened, in plain English

Epic Products is recalling Euphoric Premium Male Performance Enhancer capsules because they contain undeclared FDA-approved drugs like sildenafil and tadalafil. This makes the product an unapproved drug, which could pose health risks if used without proper medical oversight. Read more at govinfonow.com/recall/40611-euphoric-premium-male-performance-enhancer-capsules-unapproved-drug-ingredients.

Source Summary by GovInfoNow · govinfonow.com/recall/40611-euphoric-premium-male-performance-enhancer-capsules-unapproved-drug-ingredients · Updated October 7, 2026 · FDA enforcement record: FDA #D-0288-2019

Cite this page

“Euphoric Premium Male Performance Enhancer capsules: Unapproved drug ingredients.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40611-euphoric-premium-male-performance-enhancer-capsules-unapproved-drug-ingredients. Based on FDA recall #D-0288-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0288-2019%22&limit=1).

Why it’s dangerous

The product contains undeclared FDA-approved drugs such as sildenafil, tadalafil, and oxytetracycline. These drugs are approved for medical use but are marketed without proper FDA approval for this product, creating an unapproved drug that could lead to health risks.

Who’s affected

Anyone who owns or uses Euphoric Premium Male Performance Enhancer capsules with the listed UPCs. Men using these products for performance enhancement are most at risk due to potential unapproved drug ingredients.

How to tell if you have this one

Check for capsules packaged in 1-count blister cards (UPC 6 96859 28646 9), 3-count bottles (UPC 6 96859 28647 6), or 12-count bottles (UPC 6 96859 28648 3). All lots of these products are affected.

  • Brand
    Epic Products
  • Product
    Euphoric Premium Male Performance Enhancer capsules, packaged in a)1-count blister cards, UPC 6 96859 28646 9, b)
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using it now

    Immediately stop using Euphoric Premium Male Performance Enhancer capsules as they contain undeclared FDA-approved drugs.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 6.5 years after the firm started it.

1. Firm started the recall: Apr 16, 201812. Published in FDA’s Enforcement Report: Nov 21, 201823. FDA classified it Class I: Nov 30, 201834. FDA terminated the recall: Oct 3, 2024420182024
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class I
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0288-2019 (April 16, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0288-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA